Oakworth Capital’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.4K | Sell |
215
-8
| -4% | -$2.1K | ﹤0.01% | 438 |
|
|
2026
Q1 | $59.5K | Hold |
223
| – | – | ﹤0.01% | 424 |
|
|
2025
Q4 | $55.9K | Buy |
223
+26
| +13% | +$6.91K | ﹤0.01% | 416 |
|
|
2025
Q3 | $56.6K | Sell |
197
-3
| -2% | -$804 | ﹤0.01% | 421 |
|
|
2025
Q2 | $52.5K | Sell |
200
-5
| -2% | -$1.22K | ﹤0.01% | 347 |
|
|
2025
Q1 | $47.7K | Sell |
205
-1
| -0.5% | -$243 | ﹤0.01% | 359 |
|
|
2024
Q4 | $47.2K | Hold |
206
| – | – | ﹤0.01% | 365 |
|
|
2024
Q3 | $46K | Sell |
206
-2
| -1% | -$440 | ﹤0.01% | 355 |
|
|
2024
Q2 | $42.3K | Hold |
208
| – | – | ﹤0.01% | 357 |
|
|
2024
Q1 | $45.4K | Sell |
208
-100
| -32% | -$22K | ﹤0.01% | 326 |
|
|
2023
Q4 | $70K | Buy |
308
+100
| +48% | +$21K | 0.01% | 292 |
|
|
2023
Q3 | $41.8K | Sell |
208
-78
| -27% | -$16.5K | ﹤0.01% | 318 |
|
|
2023
Q2 | $59.4K | Buy |
286
+216
| +309% | +$41.9K | 0.01% | 285 |
|
|
2023
Q1 | $13.8K | Hold |
70
| – | – | ﹤0.01% | 407 |
|
|
2022
Q4 | $14.1K | Hold |
70
| – | – | ﹤0.01% | 385 |
|
|
2022
Q3 | $12K | Hold |
70
| – | – | ﹤0.01% | 426 |
|
|
2022
Q2 | $14K | Hold |
70
| – | – | ﹤0.01% | 409 |
|
|
2022
Q1 | $16K | Sell |
70
-605
| -90% | -$142K | ﹤0.01% | 406 |
|
|
2021
Q4 | $182K | Hold |
675
| – | – | 0.02% | 187 |
|
|
2021
Q3 | $163K | Hold |
675
| – | – | 0.02% | 194 |
|
|
2021
Q2 | $160K | Hold |
675
| – | – | 0.02% | 195 |
|
|
2021
Q1 | $148K | Hold |
675
| – | – | 0.02% | 196 |
|
|
2020
Q4 | $118K | Hold |
675
| – | – | 0.02% | 209 |
|
|
2020
Q3 | $109K | Hold |
675
| – | – | 0.02% | 200 |
|
|
2020
Q2 | $96K | Hold |
675
| – | – | 0.02% | 202 |
|
|
2020
Q1 | $73K | Hold |
675
| – | – | 0.02% | 211 |
|
|
2019
Q4 | $101K | Sell |
675
-9
| -1% | -$1.3K | 0.02% | 216 |
|
|
2019
Q3 | $99K | Sell |
684
-2,328
| -77% | -$340K | 0.02% | 217 |
|
|
2019
Q2 | $448K | Buy |
3,012
+9
| +0.3% | +$1.26K | 0.09% | 98 |
|
|
2019
Q1 | $395K | Hold |
3,003
| – | – | 0.08% | 106 |
|
|
2018
Q4 | $326K | Sell |
3,003
-41
| -1% | -$5.49K | 0.07% | 112 |
|
|
2018
Q3 | $454K | Sell |
3,044
-349
| -10% | -$53.1K | 0.09% | 100 |
|
|
2018
Q2 | $523K | Sell |
3,393
-175
| -5% | -$26.4K | 0.11% | 86 |
|
|
2018
Q1 | $523K | Sell |
3,568
-244
| -6% | -$35.8K | 0.13% | 75 |
|
|
2017
Q4 | $518K | Sell |
3,812
-640
| -14% | -$84.6K | 0.12% | 80 |
|
|
2017
Q3 | $600K | Hold |
4,452
| – | – | 0.15% | 71 |
|
|
2017
Q2 | $589K | Hold |
4,452
| – | – | 0.16% | 67 |
|
|
2017
Q1 | $548K | Sell |
4,452
-565
| -11% | -$66.9K | 0.16% | 73 |
|
|
2016
Q4 | $542K | Hold |
5,017
| – | – | 0.18% | 74 |
|
|
2016
Q3 | $592K | Sell |
5,017
-2,363
| -32% | -$278K | 0.21% | 68 |
|
|
2016
Q2 | $812K | Hold |
7,380
| – | – | 0.3% | 50 |
|
|
2016
Q1 | $743K | Buy |
7,380
+58
| +0.8% | +$5.56K | 0.3% | 50 |
|
|
2015
Q4 | $777K | Buy |
7,322
+7,241
| +8,940% | +$747K | 0.32% | 50 |
|
|
2015
Q3 | $8K | Hold |
81
| – | – | ﹤0.01% | 309 |
|
|
2015
Q2 | $9K | Hold |
81
| – | – | ﹤0.01% | 312 |
|
|
2015
Q1 | $8K | Buy |
81
+40
| +98% | +$4.11K | ﹤0.01% | 334 |
|
|
2014
Q4 | $4K | Hold |
41
| – | – | ﹤0.01% | 373 |
|
|
2014
Q3 | $4K | Hold |
41
| – | – | ﹤0.01% | 344 |
|
|
2014
Q2 | $4K | Hold |
41
| – | – | ﹤0.01% | 349 |
|
|
2014
Q1 | $3K | Hold |
41
| – | – | ﹤0.01% | 369 |
|
|
2013
Q4 | $3K | Buy |
+41
| New | +$3.5K | ﹤0.01% | 352 |
|
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Oakworth Capital's LH Position: Q2 2026 in Review
Oakworth Capital reduced its Labcorp (LH) stake by 3.6% in Q2 2026, selling an estimated $2.1K and leaving 215 shares worth $60.4K. The position accounts for ﹤0.01% of the portfolio, ranked #438.
Oakworth Capital first reported a position in LH in Q4 2013 and has held it in 51 quarters since. The position peaked at $812K in Q2 2016. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Oakworth Capital held 215 shares of Labcorp worth $60.4K as of Q2 2026.
- Oakworth Capital sold 8 Labcorp shares in Q2 2026, an estimated $2.1K.
- Labcorp made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #438 holding.
- Oakworth Capital first reported a position in Labcorp in Q4 2013 and has held it in 51 quarters since.
- Oakworth Capital's Labcorp position peaked at $812K in Q2 2016.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.